<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T01:22:01Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/180032" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/180032</identifier><datestamp>2025-12-06T01:55:58Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478809</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Atopic dermatitis in specialized centers in Spain: a retrospective analysis of incidence and costs (2000-2017)</dc:title>
   <dc:creator>Darbà, Josep</dc:creator>
   <dc:creator>Marsà, Alícia</dc:creator>
   <dc:subject>Dermatitis</dc:subject>
   <dc:subject>Assistència sanitària</dc:subject>
   <dc:subject>Anàlisi cost-benefici</dc:subject>
   <dc:subject>Dermatitis</dc:subject>
   <dc:subject>Medical care</dc:subject>
   <dc:subject>Cost effectiveness</dc:subject>
   <dcterms:abstract>Background Atopic dermatitis is a chronic inflammatory skin disease that has substantial effects on patients' quality of life, with a prevalence between 2.2% and 17.6% worldwide. This study aimed to evaluate the use of specialized care resources generated by children and adults with atopic dermatitis, and the associated direct medical costs. Methods Admission details from patients admitted in specialized healthcare centers (inpatient and outpatient care) in Spain between 1 January 2000 and 31 December 2017 were analyzed in a retrospective multicentre study (...)</dcterms:abstract>
   <dcterms:issued>2021-09-14T13:07:38Z</dcterms:issued>
   <dcterms:issued>2022-07-31T05:10:18Z</dcterms:issued>
   <dcterms:issued>2021-07</dcterms:issued>
   <dcterms:issued>2021-09-14T13:07:38Z</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
   <dc:relation>Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2021.1823222</dc:relation>
   <dc:relation>Expert Review of Pharmacoeconomics &amp; Outcomes Research, 2021, vol. 21, num. 4, p. 737-742</dc:relation>
   <dc:relation>https://doi.org/10.1080/14737167.2021.1823222</dc:relation>
   <dc:rights>(c) Informa Healthcare, 2021</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>Informa Healthcare</dc:publisher>
   <dc:source>Articles publicats en revistes (Economia)</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>